3tbw: Difference between revisions

Revision as of 05:56, 17 August 2011 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,097 edits m Protected "3tbw" [edit=sysop:move=sysop] ← Older edit		Revision as of 07:10, 24 August 2011 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,097 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Duru, A.D., Allerbring, E.B., Uchtenhagen, H., Mazumdar, P.A., Badia-Martinez, D., Madhurantakam, C., Sandalova, T., Nygren, P., Achour, A.		Authors: Duru, A.D., Allerbring, E.B., Uchtenhagen, H., Mazumdar, P.A., Badia-Martinez, D., Madhurantakam, C., Sandalova, T., Nygren, P., Achour, A.

	Description: CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE ~~LIGAND~~ (A2G, V3P, Y4S)		Description: CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE ligand (A2G, V3P, Y4S)

Navigation menu